Robustness of highly purified eicosapentaenoic acid trials and their cardiovascular outcomes

Journal of Cardiovascular Medicine · Published 2026-03-05 · DOI 10.2459/jcm.0000000000001857

Authors being retrieved — see the publisher record. https://doi.org/10.2459/jcm.0000000000001857

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Improved endothelial function in heart failure outpatients with reduced ejection fraction after vericiguat therapy · Journal of Cardiovascular Medicine · 2026 · Same journal
• Impact of left anterior descending lesions on 30-day mortality in very elderly STEMI patients: insights from a multicenter registry · Journal of Cardiovascular Medicine · 2026 · Same journal
• Progressive reduction in complications of cryoballoon pulmonary vein isolation for atrial fibrillation · Journal of Cardiovascular Medicine · 2026 · Same journal
• Balloon-expandable vs. self-expandable valves for small aortic annuli: which valve is better? · Journal of Cardiovascular Medicine · 2026 · Same journal
• A new milestone for the Journal of Cardiovascular Medicine · Journal of Cardiovascular Medicine · 2026 · Same journal
• Diuretic dose and right atrial function interplay in patients with tricuspid regurgitation · Journal of Cardiovascular Medicine · 2026 · Same journal
• Triglyceride-glucose index as a predictor of adverse cardiovascular outcomes in a contemporary, diverse US population undergoing percutaneous coronary intervention · Journal of Cardiovascular Medicine · 2026 · Same journal
• The effect of intravenous sodium ferric gluconate complex (Ferrlecit) on outcomes of patients undergoing transcatheter aortic valve implantation: a prospective randomized controlled trial · Journal of Cardiovascular Medicine · 2026 · Same journal
• Thrombectomy for coronary plaque erosion with large thrombus burden · Journal of Cardiovascular Medicine · 2026 · Same journal
• To reload or not to reload? Reassessing clopidogrel strategy after percutaneous coronary intervention in stable coronary disease · Journal of Cardiovascular Medicine · 2026 · Same journal